FULCRUM THERAPEUTICSCS INC
FULCRUM THERAPEUTICSCS INC
Share · US3596161097 · FULC (XNAS)
Overview Financial Indicators
6,85 USD
3,01 % 0,20 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
13.06.2025 20:00

Current Prices from FULCRUM THERAPEUTICSCS INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
FULC
USD
13.06.2025 20:00
6,85 USD
6,78 USD
+1,03 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -3,79 % 4,74 % 120,61 % 72,54 % -8,05 % -59,82 %

Company Profile for FULCRUM THERAPEUTICSCS INC Share

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia. The company is also discovering drug targets for the treatments of rare neuromuscular, muscular, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has research and discovery collaboration agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and has a strategic collaboration and license agreement with MyoKardia, Inc. to discover, develop, and commercialize novel targeted therapies for the treatment of genetic cardiomyopathies. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Invested Funds

The following funds have invested in: FULCRUM THERAPEUTICSCS INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
34,50
Percentage (%)
0,08 %

Company Data

Name FULCRUM THERAPEUTICSCS INC
Company Fulcrum Therapeutics, Inc.
Symbol FULC
Website https://www.fulcrumtx.com
Primary Exchange XNAS NASDAQ
ISIN US3596161097
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Alexander C. Sapir
Market Capitalization 174 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 26 Landsdowne Street, 02139 Cambridge
IPO Date 2019-07-18

Ticker Symbols

Name Symbol
NASDAQ FULC

More Shares

Investors who FULCRUM THERAPEUTICSCS INC hold also have the following shares in their portfolio:
ALPHABET INC - CLASS C
ALPHABET INC - CLASS C Share
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
BOEING CO
BOEING CO Share
CHARTER COMMUNICATIONS INC - CLASS A
CHARTER COMMUNICATIONS INC - CLASS A Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
FTC SOLAR INC
FTC SOLAR INC Share
INTEL CORP
INTEL CORP Share
INVESTEC BANK PLC PHOENIX KO NTS CAR 05/09/25
INVESTEC BANK PLC PHOENIX KO NTS CAR 05/09/25 Bond
MICROSOFT CORP
MICROSOFT CORP Share
ROB.CGF-R.BP US PR.EQ.DDL
ROB.CGF-R.BP US PR.EQ.DDL Fund
USA 25/27
USA 25/27 Bond
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025